133 related articles for article (PubMed ID: 38360615)
1. Exosomes secreted by Fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-FU by delivering hsa_circ_0004085.
Hui B; Zhou C; Xu Y; Wang R; Dong Y; Zhou Y; Ding J; Zhang X; Xu J; Gu Y
J Nanobiotechnology; 2024 Feb; 22(1):62. PubMed ID: 38360615
[TBL] [Abstract][Full Text] [Related]
2. Exosome-Mediated Transfer of circ_0000338 Enhances 5-Fluorouracil Resistance in Colorectal Cancer through Regulating MicroRNA 217 (miR-217) and miR-485-3p.
Zhao K; Cheng X; Ye Z; Li Y; Peng W; Wu Y; Xing C
Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33722958
[TBL] [Abstract][Full Text] [Related]
3. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer.
Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S
J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498
[TBL] [Abstract][Full Text] [Related]
4. Exosome-Derived Circ_0094343 Promotes Chemosensitivity of Colorectal Cancer Cells by Regulating Glycolysis via the miR-766-5p/TRIM67 Axis.
Li C; Li X
Contrast Media Mol Imaging; 2022; 2022():2878557. PubMed ID: 35854778
[TBL] [Abstract][Full Text] [Related]
5. Serum exosomal hsa-circ-0004771 modulates the resistance of colorectal cancer to 5-fluorouracil via regulating miR-653/ZEB2 signaling pathway.
Qiao XX; Shi HB; Xiao L
Cancer Cell Int; 2023 Oct; 23(1):243. PubMed ID: 37845688
[TBL] [Abstract][Full Text] [Related]
6. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.
Wang X; Zhang H; Yang H; Bai M; Ning T; Deng T; Liu R; Fan Q; Zhu K; Li J; Zhan Y; Ying G; Ba Y
Mol Oncol; 2020 Mar; 14(3):539-555. PubMed ID: 31901148
[TBL] [Abstract][Full Text] [Related]
7. Exosomal transfer of circular RNA FBXW7 ameliorates the chemoresistance to oxaliplatin in colorectal cancer by sponging miR-18b-5p.
Xu Y; Qiu A; Peng F; Tan X; Wang J; Gong X
Neoplasma; 2021 Jan; 68(1):108-118. PubMed ID: 33147048
[TBL] [Abstract][Full Text] [Related]
8. Circ_0007031 enhances tumor progression and promotes 5-fluorouracil resistance in colorectal cancer through regulating miR-133b/ABCC5 axis.
He X; Ma J; Zhang M; Cui J; Yang H
Cancer Biomark; 2020; 29(4):531-542. PubMed ID: 32865180
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous nuclear ribonucleoprotein L facilitates recruitment of 53BP1 and BRCA1 at the DNA break sites induced by oxaliplatin in colorectal cancer.
Hu W; Lei L; Xie X; Huang L; Cui Q; Dang T; Liu GL; Li Y; Sun X; Zhou Z
Cell Death Dis; 2019 Jul; 10(8):550. PubMed ID: 31320608
[TBL] [Abstract][Full Text] [Related]
10. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
[TBL] [Abstract][Full Text] [Related]
11. The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota.
LaCourse KD; Zepeda-Rivera M; Kempchinsky AG; Baryiames A; Minot SS; Johnston CD; Bullman S
Cell Rep; 2022 Nov; 41(7):111625. PubMed ID: 36384132
[TBL] [Abstract][Full Text] [Related]
12. Hsa_circ_0079662 induces the resistance mechanism of the chemotherapy drug oxaliplatin through the TNF-α pathway in human colon cancer.
Lai M; Liu G; Li R; Bai H; Zhao J; Xiao P; Mei J
J Cell Mol Med; 2020 May; 24(9):5021-5027. PubMed ID: 32243061
[TBL] [Abstract][Full Text] [Related]
13. Engineering lauric acid-based nanodrug delivery systems for restoring chemosensitivity and improving biocompatibility of 5-FU and OxPt against
Su M; Wen X; Yu Y; Li N; Li X; Qu X; Elsabahy M; Gao H
J Mater Chem B; 2024 Apr; 12(16):3947-3958. PubMed ID: 38586917
[TBL] [Abstract][Full Text] [Related]
14. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer.
Liang G; Zhu Y; Ali DJ; Tian T; Xu H; Si K; Sun B; Chen B; Xiao Z
J Nanobiotechnology; 2020 Jan; 18(1):10. PubMed ID: 31918721
[TBL] [Abstract][Full Text] [Related]
15. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
16. Exosomes from CD133
Zhao H; Chen S; Fu Q
J Cell Biochem; 2020 Jun; 121(5-6):3286-3297. PubMed ID: 31960989
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of circ_0004585 enhances the chemosensitivity of colorectal cancer cells to 5-fluorouracil via the miR-874-3p/CCND1 axis.
Wang S; Cao J; Pei L
Histol Histopathol; 2023 Jan; 38(1):99-112. PubMed ID: 35900059
[TBL] [Abstract][Full Text] [Related]
18. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
19. Fusobacterium nucleatum-induced exosomal HOTTIP promotes gastric cancer progression through the microRNA-885-3p/EphB2 axis.
Xin Y; Li X; Zhang M; Shang Z; Luo Z; Wang Y; Gui X; Liu Q; Li T; Zeng S; Schiöth HB; Zhang X; Zhang Y
Cancer Sci; 2023 Jun; 114(6):2360-2374. PubMed ID: 36898846
[TBL] [Abstract][Full Text] [Related]
20. Hsa_Circ_0000826 inhibits the proliferation of colorectal cancer by targeting AUF1.
Zhang Z; Fan W; Gao Q; Han Y; Ma J; Gao W; Hu Y; Zhu H; Yang R; Wang H; Du B; Zhang Z; Zhong J
J Genet Genomics; 2023 Mar; 50(3):192-203. PubMed ID: 35940521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
